Table 1.

Summary of seven case reports describing COVID‐19 patients with an erythema type eruption

Age, years	Sex	Features of erythema	Body parts where erythema appeared	Days after onset until erythema appears	No. of days that erythema appeared	Drugs used against COVID‐19
64	F	Erythematous rash	Trunk, antecubital fossa	4 days	5 days	Paracetamol
67	F	Erythematous confluent rash	Neck, trunk, back, proximal portions of upper and lower limbs	30 days (originally stated as 1 month)	7 days (originally stated as 1 month)	Hydroxychloroquine omeprazole piperacillin/tazobactam remdesivir
57	F	Erythematous confluent rash, with undefined margins, bleaching	Limbs and trunk, palms	2 days	9 days	Paracetamol
60	M	Scattered erythematous macules coalescing into papules	Back, bilateral flanks, groin and proximal lower extremities	3 days	7 days (originally stated that it turned into small round purpuric macules)	None
37	F	Erythematous maculopapular lesions	Trunk, neck and face	3 days	8 days	Acetaminophen
6	M	Maculopapular rash	Cheeks and upper and lower extremities, reaching the palms of the hands	2 days	5 days	No information
39	M	Erythematous and edematous non‐pruritic annular fixed plaques	Upper limbs, chest, neck, abdomen and palms, sparing the face and mucous membranes	0 days (the same day)	7 days	None